Back to Authors

Chan, L.

Mayo Clinic

Eli Lilly (United States)

Citations 1

Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease
Pai, Rish K. , Reinisch, Walter , Feagan, Brian G. , Agada, Noah , Pollack, P, Protić, Marijana , Hertogh, Gert D. , Reinisch, Walter , Harpaz, Noam , Chan, L., Magro, Fernando

Zeitschrift für Gastroenterologie | June 13, 2023 | Volume: 61 | Issue: 05 | Pages: e183-e184

10.1055/s-0043-1769022 Get It